Does it matter whether investigators intend to benefit research subjects?
- PMID: 21338029
Does it matter whether investigators intend to benefit research subjects?
Abstract
There has been long-standing, albeit largely implicit, debate over whether investigator intentions are relevant to the ethical appropriateness of clinical research. Some commentators argue that whether investigators intend to collect generalizable knowledge or to benefit subjects is central to the ethics of clinical research. Others do not even mention investigator intentions when evaluating what makes clinical research ethical. To shed light on this debate, the present paper considers the reasons why investigator intentions might be ethically relevant. This analysis reveals that investigator intentions are related to, but distinct from three ethical requirements: whether subjects understand that they are contributing to a project to help others, whether the included interventions have an appropriate risk/benefit ratio, and whether subjects' interests are adequately protected. Provided these three requirements are satisfied, the ethical appropriateness of clinical research does not depend on what intentions investigators have in conducting it.
Similar articles
-
The therapeutic misconception, beneficence, and respect.Account Res. 2001;8(4):331-48. doi: 10.1080/08989620108573984. Account Res. 2001. PMID: 12481794
-
Essentials of research ethics for healthcare professionals.Nurs Health Sci. 2005 Jun;7(2):119-25. doi: 10.1111/j.1442-2018.2005.00216.x. Nurs Health Sci. 2005. PMID: 15877688 Review.
-
Beyond informed consent: the therapeutic misconception and trust.J Med Ethics. 2008 Mar;34(3):202-5. doi: 10.1136/jme.2006.019406. J Med Ethics. 2008. PMID: 18316464
-
Eschewing definitions of the therapeutic misconception: a family resemblance analysis.J Med Philos. 2011 Jun;36(3):296-320. doi: 10.1093/jmp/jhr014. Epub 2011 May 23. J Med Philos. 2011. PMID: 21606116
-
The ethics of scientific investigation involving humans.Riv Ital Pediatr. 1989 Jun;15(3):223-34. Riv Ital Pediatr. 1989. PMID: 11659239 Review. No abstract available.
Cited by
-
Novel therapies, high-risk pediatric research, and the prospect of benefit: learning from the ethical disagreements.Mol Ther. 2012 Jun;20(6):1095-102. doi: 10.1038/mt.2012.90. Mol Ther. 2012. PMID: 22652997 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources